The Pelizaeus-Merzbacher disease The Lysophosphatidic acid pathway modulation to treat the Pelizaeus-Merzbacher disease Financed by : IBRO (International Brain Research Organization)Program : IBRO Return Home Fellowships 2021Duration: February 2021 to August 2023 Beneficiario: García Díaz, BeatrizImplementation centre: Hospital Regional Universitario de MálagaResearch group of IBIMA involved: Neuroimmunology and Neuroinflammation TwittearCompartirCompartir0 Compartir